Product Details for ANDA 090533
DEXTROAMPHETAMINE SULFATE (DEXTROAMPHETAMINE SULFATE)
2.5MG
Marketing Status: Prescription
5MG
Marketing Status: Prescription
7.5MG
Marketing Status: Prescription
10MG
Marketing Status: Prescription
15MG
Marketing Status: Prescription
20MG
Marketing Status: Prescription
30MG
Marketing Status: Prescription
2.5MG
Marketing Status: Prescription
Active Ingredient: DEXTROAMPHETAMINE SULFATE
Proprietary Name: DEXTROAMPHETAMINE SULFATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 2.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AA
Application Number: A090533
Product Number: 001
Approval Date: Oct 25, 2011
Applicant Holder Full Name: AZURITY PHARMACEUTICALS INC
Marketing Status: Prescription
Patent and Exclusivity Information
DEXTROAMPHETAMINE SULFATE (DEXTROAMPHETAMINE SULFATE)
Proprietary Name: DEXTROAMPHETAMINE SULFATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 2.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AA
Application Number: A090533
Product Number: 001
Approval Date: Oct 25, 2011
Applicant Holder Full Name: AZURITY PHARMACEUTICALS INC
Marketing Status: Prescription
Patent and Exclusivity Information
5MG
Marketing Status: Prescription
Active Ingredient: DEXTROAMPHETAMINE SULFATE
Proprietary Name: DEXTROAMPHETAMINE SULFATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AA
Application Number: A090533
Product Number: 002
Approval Date: Oct 25, 2011
Applicant Holder Full Name: AZURITY PHARMACEUTICALS INC
Marketing Status: Prescription
Patent and Exclusivity Information
DEXTROAMPHETAMINE SULFATE (DEXTROAMPHETAMINE SULFATE)
Proprietary Name: DEXTROAMPHETAMINE SULFATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AA
Application Number: A090533
Product Number: 002
Approval Date: Oct 25, 2011
Applicant Holder Full Name: AZURITY PHARMACEUTICALS INC
Marketing Status: Prescription
Patent and Exclusivity Information
7.5MG
Marketing Status: Prescription
Active Ingredient: DEXTROAMPHETAMINE SULFATE
Proprietary Name: DEXTROAMPHETAMINE SULFATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 7.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AA
Application Number: A090533
Product Number: 003
Approval Date: Oct 25, 2011
Applicant Holder Full Name: AZURITY PHARMACEUTICALS INC
Marketing Status: Prescription
Patent and Exclusivity Information
DEXTROAMPHETAMINE SULFATE (DEXTROAMPHETAMINE SULFATE)
Proprietary Name: DEXTROAMPHETAMINE SULFATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 7.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AA
Application Number: A090533
Product Number: 003
Approval Date: Oct 25, 2011
Applicant Holder Full Name: AZURITY PHARMACEUTICALS INC
Marketing Status: Prescription
Patent and Exclusivity Information
10MG
Marketing Status: Prescription
Active Ingredient: DEXTROAMPHETAMINE SULFATE
Proprietary Name: DEXTROAMPHETAMINE SULFATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 10MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AA
Application Number: A090533
Product Number: 004
Approval Date: Oct 25, 2011
Applicant Holder Full Name: AZURITY PHARMACEUTICALS INC
Marketing Status: Prescription
Patent and Exclusivity Information
DEXTROAMPHETAMINE SULFATE (DEXTROAMPHETAMINE SULFATE)
Proprietary Name: DEXTROAMPHETAMINE SULFATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 10MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AA
Application Number: A090533
Product Number: 004
Approval Date: Oct 25, 2011
Applicant Holder Full Name: AZURITY PHARMACEUTICALS INC
Marketing Status: Prescription
Patent and Exclusivity Information
15MG
Marketing Status: Prescription
Active Ingredient: DEXTROAMPHETAMINE SULFATE
Proprietary Name: DEXTROAMPHETAMINE SULFATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 15MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AA
Application Number: A090533
Product Number: 005
Approval Date: Oct 25, 2011
Applicant Holder Full Name: AZURITY PHARMACEUTICALS INC
Marketing Status: Prescription
Patent and Exclusivity Information
DEXTROAMPHETAMINE SULFATE (DEXTROAMPHETAMINE SULFATE)
Proprietary Name: DEXTROAMPHETAMINE SULFATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 15MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AA
Application Number: A090533
Product Number: 005
Approval Date: Oct 25, 2011
Applicant Holder Full Name: AZURITY PHARMACEUTICALS INC
Marketing Status: Prescription
Patent and Exclusivity Information
20MG
Marketing Status: Prescription
Active Ingredient: DEXTROAMPHETAMINE SULFATE
Proprietary Name: DEXTROAMPHETAMINE SULFATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 20MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AA
Application Number: A090533
Product Number: 006
Approval Date: Oct 25, 2011
Applicant Holder Full Name: AZURITY PHARMACEUTICALS INC
Marketing Status: Prescription
Patent and Exclusivity Information
DEXTROAMPHETAMINE SULFATE (DEXTROAMPHETAMINE SULFATE)
Proprietary Name: DEXTROAMPHETAMINE SULFATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 20MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AA
Application Number: A090533
Product Number: 006
Approval Date: Oct 25, 2011
Applicant Holder Full Name: AZURITY PHARMACEUTICALS INC
Marketing Status: Prescription
Patent and Exclusivity Information
30MG
Marketing Status: Prescription
Active Ingredient: DEXTROAMPHETAMINE SULFATE
Proprietary Name: DEXTROAMPHETAMINE SULFATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 30MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AA
Application Number: A090533
Product Number: 007
Approval Date: Oct 25, 2011
Applicant Holder Full Name: AZURITY PHARMACEUTICALS INC
Marketing Status: Prescription
Patent and Exclusivity Information
Proprietary Name: DEXTROAMPHETAMINE SULFATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 30MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AA
Application Number: A090533
Product Number: 007
Approval Date: Oct 25, 2011
Applicant Holder Full Name: AZURITY PHARMACEUTICALS INC
Marketing Status: Prescription
Patent and Exclusivity Information